Chemistry Reference
In-Depth Information
Fidelma Atkinson, Robert Webster, Neil Attkins, Christopher Kohl, Helena Bar-
ker, Thomas Ryckmans, James Mills, Mark Savage, Jackie Luckwell, Nick Clarke,
Simon Westbrook, Dominique Westbrook, Rachel McCoy, Gillian Burgess.
References
1. S. Montgomery, Int. J. Psych. Clin. Pract., 2006, 10(S2), 5.
2. D. S. Baldwin, Int. J. Psych. Clin. Pract., 2006, 10(S2), 12.
3. N. Ueceyler, W. Haeuser and C. Sommer, Arthritis Rheum., 2008, 58, 1279.
4. J. F. Wernicke, S. Iyengar and M. D. Ferrer-Garcia, Curr. Drug Therapy,
2007, 2, 161.
5. P. Mariappan, A. Alhasso, Z. Ballantyne, A. Grant and J. N'Dow, Eur.
Urol., 2007, 51,67.
6. S. M. Holliday and P. Benfield, Drugs, 1995, 49, 280.
7. C. M. Spencer and M. I. Wilde, Drugs, 1998, 56, 405.
8. X. Rabasseda, Drugs Today, 2004, 40, 773.
9. F. Artigas, CNS Drugs, 1995, 4, 79.
10. M. T. C. Lourenco and S. H. Kennedy, Neuropsychiatr. Dis. Treat., 2009,
5,127.
11. M. W. Walter, Drug Dev. Res., 2005, 65, 97.
12. Y. Huang and W. A. Williams, Expert Opin. Ther. Pat., 2007, 17, 889.
13. S. Liu, Shuang and B. F. Molino, Annu. Rep. Med. Chem., 2007, 42, 13.
14. G. A. Whitlock, M. D. Andrews, A. D. Brown, P. V. Fish, A. Stobie and F.
Wakenhut, in Topics in Medicinal Chemistry, ed. S. Napier, M. Bingham,
Springer, Berlin, 2009, vol. 4, chap. 3, pp. 53-94.
15. K. B. Thor and I. Yalcin, in Comprehensive Medicinal Chemistry II, ed. D.
J. Triggle and J. B. Taylor, Elsevier, Oxford, 2006, vol. 8, p. 123.
16. N. R. Zinner, Expert Opin. Investig. Drugs, 2003, 12, 1559.
17. S. P. H. Alexander, A. Mathie and J. A. Peters, Br. J. Pharmacol., 2006,
147(S3), S6.
18. S. P. H. Alexander, A. Mathie and J. A. Peters, Br. J. Pharmacol., 2006,
147(S3), S11.
19. K. B. Thor, M. Kirby and L. Viktrup, Int. J. Clin. Pract., 2007, 61, 1349.
20. M. A. Katofiasc, J. Nissen, J. E. Audia and K. B. Thor, Life Sci., 2002, 71,
1227.
21. A. Erdinc, B. Gurates, H. Celik, A. Polat, S. Kumru and M. Simsek, Arch.
Gynecol. Obstet., 2009, 279, 343.
22. R. T. Owen, Drugs Today, 2008, 44, 653.
23. F. P. Bymaster, E. E. Beedle, J. Findlay, P. T. Gallagher, J. H. Krushinski,
S. Mitchell, D. W. Robertson, D. C. Thompson, L. Wallace and D. T.
Wong, Bioorg. Med. Chem. Lett., 2003, 13, 4477.
24. D. T. Wong, Expert Opin. Investig. Drugs, 1998, 7, 1691.
25. For a detailed overview of the pre-clinical and clinical profile of duloxetine,
see label information at: www.accessdata.fda.gov/scripts/cder/drugsatfda/
index.cfm.
Search WWH ::
Custom Search